Zydus Cadila launches indigenous diabetes drug

Singapore: Indian pharma company Cadila Healthcare that operates under the aegis of Zydus Group, has launched its patent...

September 20, 2013 | Friday | News
Astellas receives approval of Irribow in Japan

Singapore: Astellas Pharma has obtained the marketing approval of Irribow OD 1 Tablets 2.5µg / 5µg (generic name: ramo...

August 19, 2013 | Monday | News
Biotron to report data from hepatitis C trial

Singapore: Biotron, a clinical-stage drug development company focused on development of new generation antiviral drugs, ...

October 16, 2012 | Tuesday | News
Biocon's novel anti-psoriasis biotech drug Itolizumab released in India

After geting the regulatory approval in early 2013, Biocon, India's number two biotech company by revenues, released the...

August 12, 2013 | Monday | News
Bioventus gets global rights for Pfizer's bone portfolio

Singapore: Bioventus, which specializes in active orthopaedic healing, has acquired exclusive, worldwide license to Pfiz...

July 4, 2013 | Thursday | News
Merck to halt Parkinson's trial due to lack of efficacy

Singapore: Merck, known as Merck Sharp & Dohme (MSD) outside the US and Canada, provided update on its clinical prog...

May 27, 2013 | Monday | News
Hong Kong to host international TCM exhibition, conference

Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ...

August 12, 2013 | Monday | News
Viralytics melanoma trial meets primary endpoint

Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...

September 18, 2013 | Wednesday | News
Oramed submits pre-IND to FDA for exenatide

Singapore: Oramed Pharmaceuticals, developer of oral drug delivery systems, submitted a pre-investigational new drug (pr...

September 4, 2013 | Wednesday | Regulatory
GE fortifies iPS cell-derived cellular assay avenue

Singapore: GE Healthcare Life Sciences has licensed Cellular Dynamics International, US-based commercial producer of hum...

December 19, 2012 | Wednesday | News
Daiichi's thrombosis drug meets primary endpoint

Singapore: Global phase III clinical trial of once-daily edoxaban for the treatment of acute symptomatic deep vein throm...

September 2, 2013 | Monday | News
J&J, Pfizer halt phase III trial of Alzheimer's drug

Singapore: Johnson & Johnson (J&J) discontinued phase III clinical development of bapineuzumab intravenous (IV) ...

August 7, 2012 | Tuesday | News
Evotec acquires Sanofi's drug discovery site

Singapore: German firm Evotec has acquired Sanofi's drug discovery operation in Toulouse to build an European centre of ...

December 4, 2014 | Thursday | News
FDA breakthrough for Roche's MS drug

Roche has announced that the US Food and Drug Administration (US FDA) has granted Breakthrough Therapy Designation for t...

February 19, 2016 | Friday | News
Prima BioMed's immunotherapeutic drug secures Japanese patent

May 3, 2016: Australia-based Prima BioMed Ltd has announced that the company has been granted patent number 5908210 enti...

May 3, 2016 | Tuesday | News
MD Anderson, Astellas collaborate to develop new drug for Acute Myeloid Leukemia

Japanese pharma giant Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center has signed an option ag...

April 8, 2015 | Wednesday | News
Merck Millipore appoints Dr Udit Batra as CEO and President

Singapore: Merck Millipore, the Life Science division of Merck, has appointed Dr Udit Batra as its new President and CEO...

April 15, 2014 | Tuesday | Influencers
US Pharmacopeial convention expands in China

Singapore: US Pharmacopeial Convention (USP), a nonprofit global health organization that creates and promotes quality s...

January 13, 2014 | Monday | Regulatory

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls